• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

MHRA

Bayer Whippany
Pharma

UK regulator approves Bayer's nonhormonal menopause drug

The U.K.’s health regulator has signed off on Bayer’s Lynkuet, a hormone-free drug to relieve moderate to severe hot flashes that accompany menopause.
Kevin Dunleavy Jul 11, 2025 11:01am
United Kingdom UK UK

UK reveals life sciences plan in sweeping strategy update

Jun 23, 2025 3:55pm
GSK

GSK kicks off Blenrep's market return with first combo nod in UK

Apr 17, 2025 2:29pm
two red lights

NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai

Mar 6, 2025 10:47am
traffic lights

England's NICE not sold on Lilly's Kisunla despite UK approval

Oct 23, 2024 11:00am
Eli Lillys Mounjaro

NHS England proposes phased rollout for Lilly's obesity med

Oct 3, 2024 3:22pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings